Clear Street’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.31K Buy
145,969
+182
+0.1% +$12 ﹤0.01% 977
2025
Q4
$9.15K Hold
145,787
﹤0.01% 795
2025
Q3
$5.39K Sell
145,787
-200
-0.1% -$14 ﹤0.01% 723
2025
Q2
$8.23K Sell
145,987
-200
-0.1% -$10 ﹤0.01% 526
2025
Q1
$3.36K Sell
146,187
-200
-0.1% -$6 ﹤0.01% 440
2024
Q4
$4.35K Sell
146,387
-132
-0.1% -$4 ﹤0.01% 422
2024
Q3
$8.4K Sell
146,519
-650
-0.4% -$38 ﹤0.01% 410
2024
Q2
$10.3K Sell
147,169
-2,776
-2% -$257 ﹤0.01% 429
2024
Q1
$11.4K Sell
149,945
-2,637
-2% -$210 ﹤0.01% 393
2023
Q4
$7.63K Hold
152,582
﹤0.01% 408
2023
Q3
$53.4K Buy
+152,582
New +$65.5K ﹤0.01% 258

Other funds holding SXTPW

Clear Street's SXTPW Position: Q1 2026 in Review

Clear Street increased its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 0.12% in Q1 2026, buying an estimated $12 and bringing the position to 145,969 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Clear Street first reported a position in SXTPW in Q3 2023 and has held it in 11 quarters since. The position peaked at $53.4K in Q3 2023. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

  • Clear Street held 145,969 shares of 60 Degrees Pharmaceuticals Warrant worth $7.31K as of Q1 2026.
  • Clear Street bought 182 60 Degrees Pharmaceuticals Warrant shares in Q1 2026, an estimated $12.
  • 60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #977 holding.
  • Clear Street first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and has held it in 11 quarters since.
  • Clear Street's 60 Degrees Pharmaceuticals Warrant position peaked at $53.4K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.